Sign in

You're signed outSign in or to get full access.

HG

Heritage Global Inc. (HGBL)·Q3 2020 Earnings Summary

Executive Summary

  • Q3 2020 revenue rose 14% year over year to $7.6M, driven by 16% growth in services revenue; operating income increased 27% YoY to $1.6M while diluted EPS was flat at $0.04. Gross profit declined to $5.0M on liquidation mix/timing; Adjusted EBITDA grew 28% YoY to $1.8M. Management highlighted strong online auction demand and an expected multi‑year uptrend in nonperforming loan (NPL) volumes. Operating income +27% YoY; Adjusted EBITDA +28% YoY .
  • Sequentially, revenue accelerated 24% q/q (Q2: $6.1M vs. Q3: $7.6M), while diluted EPS declined from $0.07 in Q2 to $0.04 in Q3 as mix and tax expense shifted; gross profit was ~$4.6M in Q2 vs. $5.0M in Q3 .
  • Balance sheet strengthened: stockholders’ equity increased to $16.0M, net cash was $5.7M, and the $5.0M credit facility remained undrawn. The company uplisted to NASDAQ and completed an equity offering (press release cites $9.1M net proceeds; CFO later referenced $8.7M) .
  • Management expects 2021–2023 to see rising NPL supply and continued strength in recommerce of industrial equipment; HGBL introduced preliminary Q3 Adjusted EBITDA guidance ($1.3–$1.7M) on Oct 2, then delivered $1.8M actual. No full‑year quantitative guidance was provided beyond this update .

What Went Well and What Went Wrong

What Went Well

  • Industrial auctions saw “record attendance” and “record pricing” amid supply chain delays for new equipment, supporting services revenue growth and improved operating leverage .
  • Strategic capital actions: uplisting to NASDAQ and an underwritten equity offering to fund higher‑contribution principal deals in Industrial Assets and specialty lending via Heritage Global Capital, enhancing growth prospects and ROIC .
  • Margin scalability: CFO detailed strong incremental margins once fixed costs are covered—~$0.70–$0.75 per $1 on Financial Assets and ~$0.40–$0.45 on Industrial Assets—supporting earnings power as volumes expand .

What Went Wrong

  • Gross profit fell YoY to $5.0M from $5.3M due to timing/mix of liquidation transactions and a shift between financial and industrial assets .
  • Sequential EPS declined to $0.04 from $0.07 in Q2 as mix/taxes shifted; net income was $1.26M in Q3 vs. $2.04M in Q2 .
  • NPL volumes remained constrained in 2020 despite bank loss reserve builds; management expects the “dam” to start opening in 2021, implying near‑term backlog but delayed revenue realization on Financial Assets .

Financial Results

MetricQ1 2020Q2 2020Q3 2020
Total Revenue ($USD Millions)$4.244 $6.117 $7.566
Services Revenue ($USD Millions)$4.088 $5.565 $6.060
Asset Sales Revenue ($USD Millions)$0.156 $0.552 $1.506
Gross Profit ($USD Millions)~$3.7 ~$4.6 $4.971
Operating Income ($USD Millions)$0.094 $1.024 $1.612
Net Income ($USD Millions)$0.038 $2.039 $1.264
Diluted EPS ($USD)$0.00 $0.07 $0.04
EBITDA ($USD Millions)$0.184 $1.114 $1.704
Adjusted EBITDA ($USD Millions)$0.259 $1.200 $1.801

Segment/Revenue Mix

Revenue Type ($USD Millions)Q1 2020Q2 2020Q3 2020
Services Revenue$4.088 $5.565 $6.060
Asset Sales$0.156 $0.552 $1.506
Total Revenue$4.244 $6.117 $7.566

KPIs and Balance Sheet Highlights

KPIPeriodValue
Stockholders’ Equity ($USD Millions)9/30/2020$15.957
Net Cash ($USD Millions)9/30/2020$5.7
Credit Facility ($USD Millions)9/30/2020$5.0 undrawn
NOL Carryforwards ($USD Millions)9/30/2020~$82.4 (unrestricted $61.6; restricted ~$20.8)

YoY Reference (Q3 2019 vs. Q3 2020, for context): Q3 2019 revenue $6.622M, gross profit $5.261M, operating income $1.267M, net income $1.216M, diluted EPS $0.04, EBITDA $1.341M, Adjusted EBITDA $1.404M .

Non‑GAAP notes: EBITDA = NI + D&A + interest/other + taxes; Adjusted EBITDA excludes stock‑based compensation. Reconciliations provided in the press release and 10‑Q filings .

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Adjusted EBITDA (non‑GAAP)Q3 2020None$1.3–$1.7M (preliminary, Oct 2) Introduced
RevenueN/ANone disclosedNo formal guidance (see earnings materials)
Margins/OpEx/Tax rateN/ANone disclosedNo formal guidance
DividendsOngoingNone; company does not expect to pay dividendsMaintained stance

Earnings Call Themes & Trends

TopicPrevious Mentions (Q-2 and Q-1)Current Period (Q3 2020)Trend
Online auctions & recommerceCOVID had minor impact; supply chain disruptions expected to increase demand for U.S.-based surplus assets “Record attendance” and “record pricing” for used equipment; strong online auction volumes Strengthening
NPL supply & Financial AssetsExpect increased supply as economy weakens; lending platforms growth a driver Pent‑up demand; banks/fintechs likely to release volumes over next 2–3 years; dam to open gradually Building backlog; multi‑year uptrend
Credit environment & underwritingTightening underwriting standards expected; demand for specialty lending HGC positioned to lend; plan to expand credit lines; partnerships to leverage first‑loss structures Capacity expansion
Pharma retooling & asset turnoverJV leasing of pharma campus; valuations support transactions Multiple Pfizer assets on books; vaccine rollout expected to free redundant equipment for secondary market Positive catalyst
Operating leverage & mix shiftSG&A benefits from Equity Partners exit; incremental margins improve with scale Focus on higher contribution principal deals; explicit incremental margin math shared Improving margin profile
Regulatory/PoliticalNot a key driver in filingsManagement neutral on election; expects volumes to rise regardless Neutral impact

Management Commentary

  • CEO on industrial demand: “We’ve seen record attendance at our auctions and record pricing… used assets are bringing a premium… demand is very high because you’re able to get those assets and purchase them real time.”
  • CEO on NPL outlook: “Pent‑up demand by the buyers of nonperforming loans… general enthusiasm there’s going to be a lot of product… probably looking at not hitting until next year.”
  • CFO on scalability: “Our overall fixed operating costs are about $10 million a year… on the financial assets side… drops about $0.75 to the bottom line… on the industrial assets side… about $0.40 to $0.45.”
  • CEO on capital strategy: Equity raised will primarily fund organic growth; bolt‑on M&A only if highly strategic; leveraging >$100M in partner commitments with first‑loss structures to scale lending .

Q&A Highlights

  • NPL cadence: Expect a measured, multi‑quarter release from lenders (non‑banks/fintech earlier than FDIC banks); no “one gigantic quarter,” more of a steady increase over 2–3 years .
  • Capital needs: Industrial principal deals recycle capital in 45–60 days; lending ties up capital for 2–4 years—hence reliance on expanded credit lines and partner capital; not planning near‑term equity issuance .
  • Sector insights: Pharma vaccine rollout likely to free secondary equipment; online auction model benefits from social distancing; resilience of secondary market surprised management .

Estimates Context

  • Wall Street consensus (S&P Global) for Q1–Q3 2020 EPS and Revenue was attempted but unavailable due to data access limits. As a result, we cannot assess beats/misses versus consensus for Q3 2020 at this time. We will update when S&P Global estimates can be retrieved [GetEstimates error].

Key Takeaways for Investors

  • Strong quarter with diversified revenue drivers: services up 16% YoY; total revenue +14% YoY; Adjusted EBITDA +28% YoY despite gross profit mix headwinds .
  • Industrial Assets segment is a near‑term engine: “record pricing” and demand for used equipment amid supply constraints; supports continued services revenue momentum .
  • Financial Assets optionality: NPL volumes likely to inflect in 2021, with a multi‑year tailwind; HGBL has credit lines and partner capital (including first‑loss arrangements) to scale lending economics .
  • Margin scalability: High incremental margins once fixed costs are covered, plus mix shift to principal deals should expand contribution over time .
  • Capital position supports growth: equity raise and net cash provide flexibility; untapped $5M revolver; NOLs (~$82.4M) enhance after‑tax cash flow potential as profitability grows .
  • Watch items: Gross profit variability tied to liquidation timing/mix; sequential EPS decline vs. Q2 reflects mix/tax—monitor mix evolution and tax impacts .
  • Near‑term trading implications: Positive narrative around industrial recommerce and upcoming NPL cycle; potential catalysts include additional principal deals, credit line expansions, and partner‑driven lending volume .

Sources: Q3 2020 8‑K press release and financial tables ; Oct 2, 2020 8‑K preliminary Adjusted EBITDA ; Q3 2020 earnings call transcripts ; Q2 2020 and Q1 2020 10‑Qs .